Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001485691 | SCV001690137 | likely benign | Holocarboxylase synthetase deficiency | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004037256 | SCV004882391 | uncertain significance | Inborn genetic diseases | 2023-09-26 | criteria provided, single submitter | clinical testing | The c.67G>A (p.D23N) alteration is located in exon 5 (coding exon 2) of the HLCS gene. This alteration results from a G to A substitution at nucleotide position 67, causing the aspartic acid (D) at amino acid position 23 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |